Surrisque de prématurité chez les nouveau-nés de femmes atteintes de polyarthrite rhumatoïde : analyse comparative appariée de la cohorte prospective GR2-RIC et des enquêtes nationales périnatales françaises
S. Hamroun(Hôpital Pontchaillou), Anna Moltó(Inserm), Aline Frazier(Inserm), Jérémie Sellam(Inserm), C. Richez(Hôpital Pellegrin), Hubert Marotte(Inserm), C. Le Ray(Hôpitaux Universitaires de Strasbourg), Rakiba Belkhir(Assistance Publique – Hôpitaux de Paris), R.M. Flipo(Hôpital Roger Salengro), N. Costedoat‐Chalumeau(Délégation Paris 5), Emmanuelle Dernis(Centre Hospitalier du Mans), Raphaèle Séror(Inserm), G. Martin de Frémont(Inserm), Marion Couderc(Centre Hospitalier Universitaire de Clermont-Ferrand), Emmanuel Chatelus(Laboratoire National de Référence), G. Guettrot-Imbert(Hôpital Cochin), Laure Gossec(Inserm), G. Elisabeth(Centre Hospitalier Universitaire de Poitiers), V. Le Gern(Hôpital Cochin), Nathalie Lelong(Inserm), V. Devauchelle Pensec(Centre Hospitalier Régional Universitaire de Brest), D. Alban(Centre Hospitalier Universitaire de Grenoble), Carsten Lukas(University Hospitals of the Ruhr-University of Bochum)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
|Annals of Oncology|2015|897
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726